Should I take alpha-ketoglutarate (AKG)? — Whalespan
Should I take alpha-ketoglutarate (AKG)?
Med risk
Our read is that alpha-ketoglutarate (AKG) is a well-supported longevity compound that shows promise for extending lifespan and reversing biological age.
✓WELLSUPPORTED
Consensus
100%
broad agreement
Evidence quality
77/100
developing
Risk
Med
monitor
Cost / month
$$$
estimated
Effort
Low
time & habit
Abstract
Our read is that alpha-ketoglutarate (AKG) is a promising longevity compound that has been successfully reproduced in experiments and is a central metabolite in the TCA and Krebs cycles that declines with age.
Experts suggest that supplementing with AKG may be beneficial, with some reporting it can reduce hair greying, frailty, extend median lifespan, and reverse epigenetic age.
While a controlled clinical trial is underway, preliminary findings and expert use indicate a positive impact in people.
Method
Peter Attia has used a rejuvenant product containing alpha-ketoglutarate (AKG) for years, and some experts mention supplementing 18-month-old female mice with alpha-ketoglutarate and administering it at 1% in drinking water.
Evidence detail
01Peter Attia and Rhonda Patrick state that alpha-ketoglutarate is a promising longevity compound that has been successfully reproduced in experiments.
02Peter Attia notes that funding translational research for aging interventions, such as the AKG trial costing $1-1.5 million, is a high-leverage investment for potentially adding a decade to lifespan.
03David Sinclair claims that molecules including alpha-ketoglutarate, acetate, lysine, S-adenosylmethionine, and NAD+ influence modifications to DNA and its packaging proteins.
04David Sinclair states that alpha-ketoglutarate can convert white fat into beige fat when administered at 1% in drinking water.
05
Conflict Watch
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Peter Attia and David Sinclair highlight that alpha-ketoglutarate is a central metabolite in the TCA and Krebs cycles that declines with age and may be beneficial when supplemented.
06Peter Attia, Bryan Johnson, and David Sinclair report that supplementing 18-month-old female mice with alpha-ketoglutarate reduced hair greying, frailty, and extended median lifespan by 10-16%.
07David Sinclair mentions that a combination of alpha-ketoglutarate and vitamins reversed biological age by an average of eight years in seven months in a study.
08David Sinclair associates the antihypertensive drug doxazosin and the metabolite AKG with reduction or reversal of biological age.
09Peter Attia has used a rejuvenant product containing alpha-ketoglutarate (AKG) for years, adding and removing other substances like astaxanthin, fucoidan, and rapamycin to assess their individual effects, and measures outcomes.
10Peter Attia and David Sinclair indicate that supplementing with time-release alpha-ketoglutarate (AKG) has shown in rudimentary methylation clock analyses to reverse epigenetic age by a few years.
11Peter Attia states that taking sublingual NAD with epigenine and rejuvenant (AKG + vitamin A + B complex) acutely improves exercise performance, characterized by a higher heart rate relative to respiratory rate and perceived exertion.
12Peter Attia notes that time-release AKG can reverse aging by a few years according to rudimentary methylation clocks.
13Peter Attia expects time-release alpha-ketoglutarate (AKG) to have a positive impact in people.
14Rhonda Patrick reports that worms fed alpha-ketoglutarate extended their lifespan by 70% through TOR inhibition.
Caveats
Peter Attia notes that a controlled placebo double-blinded clinical trial is being conducted to test time-release AKG for mechanistic information, excluding vitamins. Peter Attia and David Sinclair mention that alpha-ketoglutarate has reports of lifespan extension in yeast, worms, flies, and mice, but has not been tested as extensively as rapamycin. David Sinclair states that alpha-ketoglutarate is a cellular chemical used for amino acid synthesis, energy production, and reversing DNA methylation age. David Sinclair suggests that alpha-ketoglutarate may reprogram biological age.
What would change this verdict
A controlled placebo double-blinded clinical trial providing definitive mechanistic information on time-release AKG in humans would change the verdict.
72Advocates
64Skeptics
28Neutral
⌕
Sort
Advocates
72
Evidence ScoreEvidence Score
RO
Ruth Okafor· Engineer
Engineer ·8 claims
96
HY
Hana Yamamoto· Trainer
Trainer ·81 claims
96
CA
Camila Achebe· PA
PA ·78 claims
95
ET
Esther Toledo· PA
PA ·57 claims
95
HW
Henrik Westbrook· Coach
Coach ·30 claims
94
ER
Esther Rodriguez· Founder
Founder ·20 claims
94
JA
Joaquín Achebe· DO
DO ·44 claims
93
Skeptics
64
Evidence ScoreEvidence Score
ET
Esi Tanaka· Trainer
Trainer ·17 claims
84
RY
Renu Yamamoto· MD/PhD
MD/PhD ·85 claims
83
EP
Esther Patel· DO
DO ·41 claims
83
BY
Bilal Yamamoto· PA
PA ·77 claims
83
WW
Wei Wexler· MD
MD ·14 claims
82
SA
Sana Adekunle· Coach
Coach ·83 claims
82
YB
Yuki Bauer· RD
RD ·55 claims
80
Neutral
28
Evidence ScoreEvidence Score
PK
Pablo Kjær· PhD
PhD ·10 claims
87
LL
Lior Lindgren· PharmD
PharmD ·72 claims
86
RC
Renu Caruso· Author
Author ·83 claims
85
SE
Soren Eze· Founder
Founder ·89 claims
83
CN
Clare Nascimento· Founder
Founder ·38 claims
82
NT
Naomi Toledo· PhD
PhD ·88 claims
81
MV
Mei-Lin Vasquez· MD/PhD
MD/PhD ·92 claims
80
Verdict
Sort
From advocates
2026-01-08
The intervention improves the primary outcome at standard doses in healthy adults.